MYL9 deficiency is neonatal lethal in mice due to abnormalities in the lung and the muscularis propria of the bladder and intestine

Class II myosin complexes are responsible for muscle contraction as well as other non-sarcomeric contractile functions in cells. Myosin heavy chain molecules form the core of these structures, while light chain molecules regulate their stability and function. MYL9 is a light chain isoform that is thought to regulate non-sarcomeric myosin. However, whether this in only in specific cell types or in all cells remains unclear. To address this, we generated MYL9 deficient mice. These mice die soon after birth with abnormalities in multiple organs. All mice exhibited a distended bladder, shortening of the small intestine and alveolar overdistension in the lung. The Myl9 allele in these mice included a LacZ reporter knockin that allowed for mapping of Myl9 gene expression. Using this reporter, we show that MYL9 expression is restricted to the muscularis propria of the small intestine and bladder, as well as in the smooth muscle layer of the bronchi in the lung and major bladder vessels in all organs. This suggests that MYL9 is important for the function of smooth muscle cells in these organs. Smooth muscle dysfunction is therefore likely to be the cause of the abnormalities observed in the intestine, bladder and lung of MYL9 deficient mice and the resulting neonatal lethality.

[1]  M. Feng,et al.  Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling , 2022, Bioengineered.

[2]  Wei Zhao,et al.  Distinct Roles of Smooth Muscle and Non-muscle Myosin Light Chain-Mediated Smooth Muscle Contraction , 2020, Frontiers in Physiology.

[3]  Justin L Kandler,et al.  Compound heterozygous loss of function variants in MYL9 in a child with megacystis–microcolon–intestinal hypoperistalsis syndrome , 2020, Molecular genetics & genomic medicine.

[4]  V. Santosh,et al.  Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma , 2019, Journal of Clinical Pathology.

[5]  L. Ambartsumyan Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome Overview , 2019 .

[6]  M. Chong,et al.  Regulating gene expression in animals through RNA endonucleolytic cleavage , 2018, Heliyon.

[7]  A. Forrest,et al.  Bi‐allelic mutations in MYL1 cause a severe congenital myopathy , 2018, Human molecular genetics.

[8]  E. Pugh,et al.  Homozygous deletion in MYL9 expands the molecular basis of megacystis–microcolon–intestinal hypoperistalsis syndrome , 2018, European Journal of Human Genetics.

[9]  Y. Okamoto,et al.  Myosin light chains 9 and 12 are functional ligands for CD69 that regulate airway inflammation , 2016, Science Immunology.

[10]  Amit Kumar,et al.  Drosha controls dendritic cell development by cleaving messenger RNAs encoding inhibitors of myelopoiesis , 2015, Nature Immunology.

[11]  I. Thiffault,et al.  A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome , 2014, European Journal of Human Genetics.

[12]  J. Sellers,et al.  Myosin light chains: Teaching old dogs new tricks , 2014, Bioarchitecture.

[13]  M. Tekin,et al.  De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis , 2014, Human Genetics.

[14]  Michael F. Wangler,et al.  Heterozygous De Novo and Inherited Mutations in the Smooth Muscle Actin (ACTG2) Gene Underlie Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome , 2014, PLoS genetics.

[15]  V. Dugina,et al.  Smooth muscle actin isoforms: a tug of war between contraction and compliance. , 2013, European journal of cell biology.

[16]  H. Gerhardt,et al.  SRF selectively controls tip cell invasive behavior in angiogenesis , 2013, Development.

[17]  M. Higashihara,et al.  Surface CD3 expression proceeds through both myosin regulatory light chain 9 (MYL9)-dependent and MYL9-independent pathways in Jurkat cells. , 2012, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[18]  M. Chong,et al.  Many routes to a micro RNA , 2011, IUBMB life.

[19]  P. Puri,et al.  Megacystis microcolon intestinal hypoperistalsis syndrome: systematic review of outcome , 2011, Pediatric Surgery International.

[20]  D. H. Kim,et al.  Myosin regulatory light chains are required to maintain the stability of myosin II and cellular integrity. , 2011, The Biochemical journal.

[21]  D. Milewicz,et al.  De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction , 2010, American journal of medical genetics. Part A.

[22]  D. Bluteau,et al.  MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. , 2009, Blood.

[23]  H. Thomas,et al.  Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. , 2004, The American journal of pathology.

[24]  M. Bader,et al.  Smooth-muscle contraction without smooth-muscle myosin , 2000, Nature Cell Biology.

[25]  C. Begley,et al.  SCL expression in the mouse embryo detected with a targeted lacZ reporter gene demonstrates its localization to hematopoietic, vascular, and neural tissues. , 1999, Blood.

[26]  R. Wadgaonkar,et al.  Localization of the gene coding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23-q24.3. , 1992, Genomics.

[27]  B. Nadal-Ginard,et al.  Mammalian nonsarcomeric myosin regulatory light chains are encoded by two differentially regulated and linked genes [published erratum appears in J Cell Biol 1990 Nov;111(5 Pt 1):2207] , 1990, The Journal of cell biology.

[28]  H. Arnold,et al.  Identification of the functional promoter regions in the human gene encoding the myosin alkali light chains MLC1 and MLC3 of fast skeletal muscle. , 1989, The Journal of biological chemistry.

[29]  J. Frézal,et al.  Chromosomal assignment of two myosin alkali light-chain genes encoding the ventricular/slow skeletal muscle isoform and the atrial/fetal muscle isoform (MYL3, MYL4) , 1989, Human Genetics.